United States - English - NLM (National Library of Medicine)

caraco pharmaceutical laboratories, ltd. - baclofen (unii: h789n3fke8) (baclofen - unii:h789n3fke8) - tablet - baclofen is useful for the alleviation of signs and symptoms of spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms and concomitant pain, clonus, and muscular rigidity. patients should have reversible spasticity so that baclofen treatment will aid in restoring residual function. baclofen may also be of some value in patients with spinal cord injuries and other spinal cord diseases. baclofen is not indicated in the treatment of skeletal muscle spasm resulting from rheumatic disorders. the efficacy of baclofen in stroke, cerebral palsy, and parkinson's disease has not been established and, therefore, it is not recommended for these conditions. hypersensitivity to baclofen.

Malta - English - Medicines Authority

generics uk limited station close, potters bar, herts, en6 1tl, united kingdom - baclofen - tablet - baclofen 10 mg - muscle relaxants

Malta - English - Medicines Authority

syri pharma limited floor 0 1 wml, 1 windmill lane dublin 2, d02 f206, ireland - baclofen - oral solution - baclofen 10 mg/5ml - muscle relaxants

Canada - English - Health Canada

teva canada limited - baclofen - tablet - 10mg - baclofen 10mg - gaba-derivative skeletal muscle relaxants

Canada - English - Health Canada

teva canada limited - baclofen - tablet - 20mg - baclofen 20mg - gaba-derivative skeletal muscle relaxants

Canada - English - Health Canada

laboratoire riva inc. - baclofen - tablet - 10mg - baclofen 10mg - gaba-derivative skeletal muscle relaxants

Canada - English - Health Canada

laboratoire riva inc. - baclofen - tablet - 20mg - baclofen 20mg - gaba-derivative skeletal muscle relaxants

Ireland - English - HPRA (Health Products Regulatory Authority)

syri limited, t/a thame laboratories - baclofen - oral solution - 5 mg/5ml - other centrally acting agents; baclofen

New Zealand - English - Medsafe (Medicines Safety Authority)

boucher & muir (new zealand) limited t/a bnm group - baclofen 0.5 mg/ml - solution for infusion - 0.5 mg/ml - active: baclofen 0.5 mg/ml excipient: sodium chloride water for injection - intrathecal baclofen is indicated in patients with severe chronic spasticity of spinal origin (associated with injury, multiple sclerosis, or other spinal cord diseases) or of cerebral origin who are unresponsive to orally administered antispastics (including oral baclofen) and/or who experience unacceptable side effects at effective oral doses.

New Zealand - English - Medsafe (Medicines Safety Authority)

boucher & muir (new zealand) limited t/a bnm group - baclofen 2 mg/ml - solution for infusion - 2 mg/ml - active: baclofen 2 mg/ml excipient: sodium chloride water for injection - intrathecal baclofen is indicated in patients with severe chronic spasticity of spinal origin (associated with injury, multiple sclerosis, or other spinal cord diseases) or of cerebral origin who are unresponsive to orally administered antispastics (including oral baclofen) and/or who experience unacceptable side effects at effective oral doses.